{"id":49,"date":"2026-04-08T03:44:47","date_gmt":"2026-04-08T03:44:47","guid":{"rendered":"https:\/\/www.europesays.com\/ai\/49\/"},"modified":"2026-04-08T03:44:47","modified_gmt":"2026-04-08T03:44:47","slug":"colossal-biosciences-the-moonshot-that-became-a-business","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ai\/49\/","title":{"rendered":"Colossal Biosciences: The Moonshot That Became a Business"},"content":{"rendered":"<p><img fetchpriority=\"high\" decoding=\"async\" aria-describedby=\"caption-attachment-1041663\" class=\"wp-image-1041663 size-full lazyload\" alt=\"\" width=\"1280\" height=\"909\" src=\"https:\/\/www.europesays.com\/ai\/wp-content\/uploads\/2026\/04\/Dire-Wolf-6885.webp\"  data- data-eio-rwidth=\"1280\" data-eio-rheight=\"909\"\/><\/p>\n<p id=\"caption-attachment-1041663\" class=\"wp-caption-text\">Ben Lamm co-founded Colossal Biosciences with Harvard geneticist George Church in 2021<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">By Futurist Thomas Frey<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">In April 2025, three wolf pups were born that shouldn\u2019t exist.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Their names were Romulus, Remus, and Khaleesi. They were healthy, they were photographed, and they made the cover of Time magazine. They were also, genetically speaking, something the world hadn\u2019t seen in 13,000 years. The dire wolf \u2014 the apex predator of the Ice Age, the creature that once ruled North America alongside the woolly mammoth and the saber-toothed cat \u2014 had been gone since before recorded human history.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Then Ben Lamm brought it back.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Peter Diamandis, who has spent his career finding the most audacious things happening in science and technology, called it the scientific miracle of the decade. He\u2019s not given to overstatement.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">But here\u2019s the thing most people missed in all the excitement: the wolf wasn\u2019t the goal. It was the proof.<\/p>\n<p>What They\u2019re Actually Building<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Ben Lamm co-founded Colossal Biosciences with Harvard geneticist George Church in 2021. When he announced that the company intended to bring back the woolly mammoth, most people assumed it was a publicity stunt \u2014 a flashy headline wrapped around a research project that would never really get anywhere.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">They were wrong about that.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">What Lamm understood from the beginning is that you don\u2019t build a company around an animal. You build it around the tools you need to get to the animal. And those tools \u2014 new ways to read ancient DNA, new methods for editing genes with surgical precision, new technology for growing embryos outside a living body \u2014 those turn out to be useful for a lot more than bringing back one extinct species.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Think of it this way. When NASA developed materials that could survive the heat of reentry from space, those materials didn\u2019t stay in rockets. They ended up in everything from firefighting gear to running shoes. The technology built for one extreme purpose found its way into everyday life because the underlying science was genuinely new and genuinely powerful.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">That\u2019s what Colossal is doing with biology. The de-extinction projects are the extreme purpose. The tools being built to achieve them are the real product.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-1041662\" class=\"wp-image-1041662 size-full lazyload\" alt=\"\" width=\"1600\" height=\"1200\" data-eio=\"p\" src=\"https:\/\/www.europesays.com\/ai\/wp-content\/uploads\/2026\/04\/Dire-Wolf-6884.jpg\"  data- data-eio-rwidth=\"1600\" data-eio-rheight=\"1200\"\/><\/p>\n<p id=\"caption-attachment-1041662\" class=\"wp-caption-text\">Extinction isn\u2019t permanent anymore. With $10B backing and gene editing breakthroughs, life itself is becoming programmable\u2014revived, redesigned, and repurposed at a scale we\u2019re just beginning to grasp.<\/p>\n<p>The Numbers Tell the Story<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">By January 2025, Colossal had raised $435 million in total funding. A $200 million Series C round valued the company at $10.2 billion, making it Texas\u2019s first decacorn \u2014 a startup worth more than ten billion dollars. The investor list includes venture capitalists, institutional funds, and more than a few celebrities whose names you\u2019d recognize. That\u2019s not an accident. Lamm has always understood that a company trying to do something this large needs cultural momentum, not just scientific credibility.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">But the science is what earns the valuation. To bring back the dire wolf, Colossal\u2019s team extracted usable DNA from a 13,000-year-old tooth and a 72,000-year-old ear bone. They reconstructed the genome, identified the 20 key traits that made a dire wolf a dire wolf, and rewrote 14 genes in 45 engineered eggs. Those eggs became embryos. Those embryos were carried by surrogate hound mixes. Those surrogates gave birth to three healthy pups.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">It worked. On the first attempt at this scale. That is not a small thing.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The mammoth program has already produced what the team calls \u201cwoolly mice\u201d \u2014 ordinary lab mice gene-edited with mammoth DNA traits, including the distinctive shaggy tawny fur \u2014 as a proof that the genetic approach works before they try it on something the size of a bus. The Tasmanian tiger program has reconstructed a 99.9% accurate genome from a 110-year-old skull. A partnership with filmmaker Peter Jackson and the indigenous M\u0101ori people of New Zealand is underway to attempt to bring back the moa, a giant flightless bird that disappeared after human settlement of the islands.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Each project is different. Each one pushes the tools further. And each time the tools get pushed further, they get more useful for everything else.<\/p>\n<p>The Part Nobody\u2019s Talking About<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">There\u2019s a piece of the Colossal story that gets almost no attention in the mainstream coverage, but that may turn out to matter more than the animals themselves. It\u2019s the artificial womb program.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Here\u2019s the problem it solves. To bring back an extinct species, you usually need a living relative that\u2019s close enough in biology to carry the embryo. For the woolly mammoth, that relative is the Asian elephant. But the Asian elephant is itself endangered \u2014 and Lamm has been consistent and clear that Colossal will not put endangered animals through invasive reproductive procedures to serve the mammoth project. So they\u2019re building a womb instead. An artificial one. A device that can take a fertilized single-cell embryo and bring it all the way to a live birth without a living surrogate.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Lamm has said publicly that he expects this to work \u2014 with a small mammal first, then scaling up \u2014 by the end of 2026. If it does, the implications go well beyond anything Colossal is currently working on. A technology that can grow a living mammal from a single cell to birth in an artificial environment is not a tool that stays in one laboratory. What it means for the survival of critically endangered species, for the future of reproductive medicine, for conservation biology across the board \u2014 that conversation is only just beginning.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Lamm has drawn a clear line: Colossal won\u2019t apply this technology to humans or non-human primates. But drawing a line around your own use of a tool doesn\u2019t make the tool disappear. It just means someone else will eventually have to decide where to draw theirs.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-1041659\" class=\"wp-image-1041659 size-full lazyload\" alt=\"\" width=\"1920\" height=\"1378\" data-eio=\"p\" src=\"https:\/\/www.europesays.com\/ai\/wp-content\/uploads\/2026\/04\/Dire-Wolf-6881.jpg\"  data- data-eio-rwidth=\"1920\" data-eio-rheight=\"1378\"\/><\/p>\n<p id=\"caption-attachment-1041659\" class=\"wp-caption-text\">Startup speed meets science\u2014extinction is shifting from fate to choice. What once took decades now happens in years, turning resurrection into a commercial, repeatable reality.<\/p>\n<p>A Tech Company Wearing a Lab Coat<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">What makes Lamm\u2019s approach genuinely different from how science normally works is that he\u2019s running Colossal the way he ran his software companies. Fast. Capital-intensive. Outcome-focused. Willing to hire the best people from academia and pay them what the private sector pays, which is not what universities pay. Willing to fail publicly and talk about it openly, which scientists are not traditionally trained to do. And obsessively focused on the question of how the technology gets commercialized \u2014 because without a business model, there is no mission.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The result is a company that has moved faster in four years than the academic de-extinction community moved in twenty. That\u2019s not a criticism of the scientists who came before. It\u2019s a description of what happens when you apply startup discipline to a problem that used to live entirely inside universities.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The dire wolf is alive. The woolly mouse exists. The Tasmanian tiger\u2019s genome is reconstructed and waiting. These are not predictions about the future. They are things that have already happened.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The mammoth is next. And after that, if Ben Lamm has his way, extinction itself becomes optional.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Next week: Form Bio \u2014 the AI scientific software platform that Colossal built for itself, then realized the entire life sciences industry needed.<\/p>\n<p>Related Reading<br \/>\n<a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/www.science.org\/content\/article\/scientists-have-revived-dire-wolf-sort\" rel=\"nofollow noopener\" target=\"_blank\">Dire Wolf De-Extinction: The Science Behind Colossal\u2019s Breakthrough<\/a><\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Science \u2014 A rigorous look at the genomic methodology behind the dire wolf project, what the science actually claims, and where skeptics draw the line between restoration and approximation<\/p>\n<p><a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/www.technologyreview.com\/2025\/01\/colossal-series-c-valuation\/\" rel=\"nofollow noopener\" target=\"_blank\">Colossal Biosciences\u2019 $10.2 Billion Bet on De-Extinction<\/a><\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">MIT Technology Review \u2014 How a genomics startup became a decacorn, what the capital structure reveals about where biotech investment is heading, and why the mammoth is the last thing on investors\u2019 minds<\/p>\n<p><a class=\"underline underline underline-offset-2 decoration-1 decoration-current\/40 hover:decoration-current focus:decoration-current\" href=\"https:\/\/www.theatlantic.com\/science\/archive\/2023\/pleistocene-park-mammoth-permafrost\/\" rel=\"nofollow noopener\" target=\"_blank\">Pleistocene Park and the Climate Case for De-Extinction<\/a><\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">The Atlantic \u2014 The ecological argument for restoring megafauna to Arctic grasslands, and whether the return of large herbivores could meaningfully slow permafrost melt \u2014 the climate rationale beneath Colossal\u2019s flagship project<\/p>\n","protected":false},"excerpt":{"rendered":"Ben Lamm co-founded Colossal Biosciences with Harvard geneticist George Church in 2021 By Futurist Thomas Frey In April&hellip;\n","protected":false},"author":2,"featured_media":50,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[24,25,54,55,56],"class_list":{"0":"post-49","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ai","8":"tag-ai","9":"tag-artificial-intelligence","10":"tag-ben-lamm","11":"tag-dna","12":"tag-george-church"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/49","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/comments?post=49"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/49\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media\/50"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media?parent=49"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/categories?post=49"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/tags?post=49"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}